Inhibitors of NLRP3 activation for treatment of inflammatory CNS diseases [ 2015 - 2017 ]

Research Grant

Researchers: A/Pr Trent Woodruff (Principal investigator) ,  Prof Matthew Cooper (Principal investigator) ,  A/Pr Kate Schroder

Brief description This project will use novel tool compounds to advance our understanding of inflammatory brain diseases such as Parkinson's disease and Multiple Sclerosis. We will examine the molecular pathways and identify novel means to treat these debilitating diseases. We will then aim to design novel therapeutics which target these pathways.

Funding Amount $AUD 1,023,137.82

Funding Scheme Project Grants

Notes Standard Project Grant